Cited by 908Fatty Acid Research and HealthInflammatory mediators and NSAID effectsEicosanoids and Hypertension Pharmacology

Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions

Open access
Serhan, Charles N., Yang, Rong, Martinod, Kimberly, Kasuga, Kie, Pillai, Padmini S., Porter, Timothy F., Oh, Sungwhan F., Spite, Matthew·2009·Journal of Experimental Medicine

Abstract

The endogenous cellular and molecular mechanisms that control acute inflammation and its resolution are of wide interest. Using self-resolving inflammatory exudates and lipidomics, we have identified a new pathway involving biosynthesis of potent antiinflammatory and proresolving mediators from the essential fatty acid docosahexaenoic acid (DHA) by macrophages (MPhis). During the resolution of mouse peritonitis, exudates accumulated both 17-hydroxydocosahexaenoic acid, a known marker of 17S-D series resolvin (Rv) and protectin biosynthesis, and 14S-hydroxydocosa-4Z,7Z,10Z,12E,16Z,19Z-hexaenoic acid from endogenous DHA. Addition of either DHA or 14S-hydroperoxydocosa-4Z,7Z,10Z,12E,16Z,19Z-hexaenoic acid to activated MPhis converted these substrates to novel dihydroxy-containing products that possessed potent antiinflammatory and proresolving activity with a potency similar to resolvin E1, 5S,12R,18R-trihydroxyeicosa-6Z,8E,10E,14Z,16E-pentaenoic acid, and protectin D1, 10R,17S-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid. Stable isotope incorporation, intermediate trapping, and characterization of physical and biological properties of the products demonstrated a novel 14-lipoxygenase pathway, generating bioactive 7,14-dihydroxydocosa-4Z,8,10,12,16Z,19Z-hexaenoic acid, coined MPhi mediator in resolving inflammation (maresin), which enhances resolution. These findings suggest that maresins and this new metabolome may be involved in some of the beneficial actions of DHA and MPhis in tissue homeostasis, inflammation resolution, wound healing, and host defense.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20081880

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The differences in effects of EPA and DHA could be due to structural characteristics of the two fatty acids and their ability to produce different metabolite species.

    “The differences identified could be due to structural characteristics of the two fatty acids as well as their ability to produce different metabolite species [137,138].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M.
Affiliations
Brigham and Women's Hospital (US)
Venue
Journal of Experimental Medicine
Published
2008-12-22
Volume
206
Issue
1
Pages
15-23
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2122405246
Cited by
908
References
33
Citations by year
2026: 36 · 2025: 40 · 2024: 54 · 2023: 47 · 2022: 67 · 2021: 56 · 2020: 59 · 2019: 65 · 2018: 55 · 2017: 54 · 2016: 40 · 2015: 52 · 2014: 60 · 2013: 66 · 2012: 48
FWCI
34.35
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • National Institutes of Health (4r37gm038765-19, DE016191, GM038765)
  • National Institute of General Medical Sciences (R37-GM038765)
  • National Institute of Dental and Craniofacial Research (P50DE016191)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
maresins, macrophages, inflammation resolution, docosahexaenoic acid, resolvin E1, protectin D1, peritonitis, lipidomics, wound healing
MeSH terms
Animals, Anti-Inflammatory Agents, Non-Steroidal, Cell Movement, Docosahexaenoic Acids, Humans, Leukocytes, Mononuclear, Lipoxygenase, Macrophages, Mice, Inbred Strains, Neutrophils, Peritonitis, Phagocytosis, Autacoids, Stereoisomerism, Zymosan, Eicosapentaenoic Acid, Dinoprostone, Molecular Structure, Macrophages, Peritoneal, Inflammation Mediators, Lipid Metabolism, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review